Palonosetron [palonosetron]
- Terms
-
Aloxi
palonosetroni hydrochloridum
-
2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one
2-QHBIQO
Aloxi
Palonosetron Hydrochloride
Palonosetron, (3R)-
Palonosetron, (R-(R*,R*))-isomer
Palonosetron, (R-(R*,S*))-isomer
Palonosetron, (S-(R*,S*))-isomer
RS 25233-197
RS 25233-198
RS 25259
RS 25259-197
RS 25259-198
RS-25233-197
RS-25233-198
RS-25259
RS-25259-197
RS-25259-198
Isoquinoline and quinuclidine derivative that acts as a 5-HT3 RECEPTOR antagonist. It is used in the prevention of nausea and vomiting induced by cytotoxic chemotherapy, and for the prevention of post-operative nausea and vomiting.
- DUI
- D000077924 MeSH Browser
- CUI
- M0221985
- CAS
- 1H-Benz(de)isoquinolin-1-one, 2-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (3aS)-
- History note
- 2019 (1993)
- Public note
- 2019; PALONOSETRON was indexed under ISOQUINOLINES and QUINUCLIDINES 1993-2018
Allowable subheadings
- AD
- administration & dosage 3
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 3
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 3
- TO
- toxicity
- UR
- urine